Gerresheimer AG

Gerresheimer AG

GRRMF

$29.05

Updated: 22/09/2026, 16:00:06

Market Cap
$1.00B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
DE
Stock valuation chart
One-year closing share-price history for GRRMF
Company Profile

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. This segment also produces various plastic containers and closures, such as PET bottles, eye droppers, nasal sprays, nebulizers, and applicators, suitable for solid, liquid, and ophthalmic preparations, in addition to bottles for nutritional supplements. Its Primary Packaging Glass division specializes in essential glass packaging for both pharmaceutical and cosmetic industries. Offerings include infusion, dropper, and syrup bottles, injection vials, ampoules, and cartridges. This division also provides miniature bottles and glass containers for liquid food, spices, and spirits, as well as sophisticated packaging for fragrances, deodorants, skincare, wellness items, and diverse beauty and pharmaceutical products. The Advanced Technologies division is dedicated to pioneering smart drug delivery systems. A notable innovation is its micro-pumps, which empower patients to self-administer medications for conditions like Parkinson's disease or heart failure, catering to pharmaceutical and biotech clients. Established in 1864, the company's corporate headquarters are located in Düsseldorf, Germany.

USD
OTC
CEO: Uwe Ferdinand Röhrhoff
Employees: 13,528
https://www.gerresheimer.com
Asset Summaries
Latest generated summaries for GRRMF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for GRRMF.
Share price
$29.05
Market cap
$1.00B
Exchange
OTC
Currency
USD
CEO
Uwe Ferdinand Röhrhoff
Employees
13,528
IPO date
11/09/2009
Beta
0.473
Last dividend
$0.00
Day range
$29.05 – $32.20
52-week range
$19.17 – $51.41
1-day performance
-9.78%
1-year performance
51.58%
Current drawdown (1Y)
-43.49%
CIK
N/A
CUSIP
N/A
ISIN
DE000A0LD6E6
Created
07/12/2025, 04:25:13
Last update
22/09/2026, 16:00:06

Track Gerresheimer AG with an AI analyst

See which prediction-market events move GRRMF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.